
Investor Relations Captor Therapeutics ®
Shareholders
Shareholder | Total number of shares | Total number of votes | Percentage of share capital | Percentage of total votes at the GSM | |
---|---|---|---|---|---|
1. | Michał Walczak | 933 528 | 1 473 545 | 16,99% | 22,20% |
2. | Paweł Holstinghausen-Holsten | ||||
directly | 363 186 | 723 261 | 6,61% | 10,89% | |
indirectly via the Holstinghausen-Holsten Family Foundation | 236 112 | 236 1112 | 4,30% | 3,55% | |
total | 599 298 | 959 373 | 10,91% | 14,44% | |
3. | Sylvain Cottens | 340 897 | 526 730 | 6,20% | 7,93% |
4. | TFI Allianz Polska S.A. | 343 483 | 343 483 | 6,25% | 5,17% |
5. | Funds Managed by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 303 075 | 303 075 | 5,51% | 4,56% |
6. | Others | 2 975 290 | 3 035 758 | 54,14% | 45,70% |
Total | 5 495 571 | 6 642 964 | 100,00% | 100,00% |